title: Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma.
abstract: Locally advanced gastric adenocarcinoma has a poor outcome. Neoadjuvant treatment is being tested in locally advanced non-resectable tumours and in those resectable tumours with a high risk of recurrence. Efforts to identify prognostic factors and more active and less toxic preoperative regimens are being searched for. We report the case of a patient achieving a complete histopathological complete response following docetaxel- based neoadjuvant chemotherapy.
authors.affiliation: Servicio de Oncología Médica, Hospital Clínico San Carlos, Madrid, Spain. corabumu@hotmail.com
authors.forename: C
authors.initials: C
authors.lastname: Bueno Muiño
authors.forename: J
authors.initials: J
authors.lastname: Puente Vázquez
authors.forename: J
authors.initials: J
authors.lastname: Sastre Valera
authors.forename: J A
authors.initials: JA
authors.lastname: García-Sáenz
authors.forename: M
authors.initials: M
authors.lastname: Martín
authors.forename: N
authors.initials: N
authors.lastname: García Miralles
authors.forename: A
authors.initials: A
authors.lastname: Sánchez-Pernaute
authors.forename: E
authors.initials: E
authors.lastname: Díaz-Rubio
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D018450:Disease Progression; D000077143:Docetaxel; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D013274:Stomach Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel